Tokyo, Aug. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062334) titled 'A Retrospective Observational Study Evaluating Treatment Response in Patients with PNH on Anti-C5 Antibody Therapy: Japanese Chart Review Study' on July 31.
Study Type:
Observational
Primary Sponsor:
Institute - Japan PNH Study Group / Novartis Pharma K.K.
Condition:
Condition - Paroxysmal Nocturnal Hemoglobinuria
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Although anti-C5 antibody therapy has improved treatment outcomes in PNH, anemia and hemolysis-related symptoms may persist in some patients with PNH. This study aimed to characterize real-world treatment re...